PITTSBURGH & MINNEAPOLIS--(BUSINESS WIRE)--Blue Belt Technologies, Inc., an innovative medical technology company commercializing robotic-assisted solutions for orthopedic surgery, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its STRIDE™ Unicondylar Knee implant system. The STRIDE implant will be co-marketed with Blue Belt Technologies’ NavioPFS™ precision orthopedic surgical system which has been commercially available in the U.S. since December, 2012. “Additionally, we remain focused and committed to continuing to build out NavioPFS’s open architecture for implant selection. Allowing our customers to adopt technology...
↧